ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2812

Evaluation of Cortical Microarchitecture, Bone Stiffness and Bone Remodeling in Patients with Atypical Femoral Fracture

Mariana O Perez1, Diogo S Domiciano1, Luciene M Reis2, Vanda Jorgetti2 and Rosa M R Pereira1, 1Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, 2Nephrology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Bisphosphonates, Bone, bone disease, bone remodeling and fractures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T087 ACR Abstract: Osteoporosis & Metabolic Bone Disease–Basic & Clinical Science (2808–2813)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Atypical femoral fractures (AFF) are low energy femoral fractures and subtrochanteric/diaphyseal localization that have been related to long-term bisphosphonate therapy. Patients with AFF exhibit cortical thickening in femoral shaft, suggesting that AFF may occur due to cortical stress. Analysis of cortical bone microarchitecture, biomechanical properties of bone and bone remodeling in AFF are poorly explored in the literature. Our aim is to evaluate patients with AFF including: 1) cortical bone microarchitecture and bone stiffness by high resolution peripheral quantitative computed tomography (HR-pQCT) and 2) cortical microarchitecture and parameters of bone remodeling by bone histomorphometry of iliac crest.

Methods: Eighteen patients with AFF by the American Society of Bone Mineral Research. Cortical bone parameters (cortical volumetric bone mineral density: Ct.vBMD, mgHA/cm3; and cortical thickness: Ct.Th, mm) and bone stiffness (S, kN/mm) were studied at tibia and distal radius by HR-pQCT and compared to healthy controls matched for sex and age. Cortical thickness (Ct.Th, μm) and bone remodeling (bone formation rate: BFR/BS, μm3/μm2/day) were assessment (Osteomeasure software®) and compared with healthy individuals matched for sex and age.

Results: The mean age of the patients was 64.9±13.3 years old, 94.4% women and 72.2% Caucasian. Seventeen used bisphosphonates (5.8±2.7 years) and 83.3% alendronate at the time of fracture. One patient was on denosumab, but had received bisphosphonate for 6 years. Presence of rheumatic disease was observed in 50% of the patients, most of them with rheumatoid arthritis and 44.4% of the patients used oral glucocorticoid. All fractures were diaphyseal, of which 16 (88.8%) were complete and 4 (22.2%) were bilateral. HR-pQCT (n=12) at tibia showed decreased/normal Ct.vBMD in 83.3% and decreased/normal Ct.Th in 91.6% of the patients. Similar findings were observed at distal radius. Seventy-five percent of the patients had decreased S at tibia and 58.3% at radius. At tibia, S was positively correlated with Ct.Th (r = 0.783, p = 0.001) and Ct.vBMD (r = 0.573, p = 0.004). At radio, S was positively correlated with Ct.Th (r = 0.720, p = 0.007). Bone histomorphometry (n=6) exhibited Ct.Th decreased in 66.6% and normal in 33.3% of the cases. All patients had suppressed bone remodeling.

Conclusion: Our data suggest that AFF patients maintain bone fragility observed in peripheral sites (tibia and radius) and in the iliac crest. Impairment of cortical microarchitecture associated with decreased bone stiffness and suppression of bone remodeling would explain bone fragility in these patients. Our data warn that the cortical bone should be contemplated in the treatment of AFF.


Disclosure: M. O. Perez, None; D. S. Domiciano, None; L. M. Reis, None; V. Jorgetti, None; R. M. R. Pereira, None, 2.

To cite this abstract in AMA style:

Perez MO, Domiciano DS, Reis LM, Jorgetti V, Pereira RMR. Evaluation of Cortical Microarchitecture, Bone Stiffness and Bone Remodeling in Patients with Atypical Femoral Fracture [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-cortical-microarchitecture-bone-stiffness-and-bone-remodeling-in-patients-with-atypical-femoral-fracture/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-cortical-microarchitecture-bone-stiffness-and-bone-remodeling-in-patients-with-atypical-femoral-fracture/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology